跳到主要內容

Dudum Andrew 的 Form 4 申報

Hims & Hers Health, Inc.(HIMS),2025/7/18 申報

申報編號
0001773751-25-000235
申報時間
2025/7/18
交易日
2025/7/16
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $253.0 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Dudum AndrewCIK 0001837796董事、高階主管(執行長)、持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2025/7/16Class A Common StockS賣出處分−2,792$50.58F2−$141,219.3692,313直接
2025/7/16Class A Common StockS賣出處分−1,458$50.82F3−$74,095.56236,202間接
2025/7/16Class A Common StockS賣出處分−46,076$50.24F4−$2,314,858.24190,126間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.47 - $50.745. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.79 - $50.89. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.80 - $50.785. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)